254 related articles for article (PubMed ID: 17497996)
1. Double filtration plasmapheresis can decrease factor XIII Activity.
Hanafusa N; Kondo Y; Suzuki M; Nakao A; Noiri E; Fujita T
Ther Apher Dial; 2007 Jun; 11(3):165-70. PubMed ID: 17497996
[TBL] [Abstract][Full Text] [Related]
2. Virus removal and eradication by modified double filtration plasmapheresis decreases factor XIII levels.
Hanafusa N; Satonaka H; Doi K; Noiri E; Fujita T
Ther Apher Dial; 2010 Jun; 14(3):287-91. PubMed ID: 20609180
[TBL] [Abstract][Full Text] [Related]
3. Decreased factor XIII activity in a patient with subcutaneous bleeding after double filtration plasmapheresis.
Seishima M; Shibuya Y; Kato G; Aoki T
Ther Apher Dial; 2009 Jun; 13(3):229-31. PubMed ID: 19527471
[TBL] [Abstract][Full Text] [Related]
4. Reducing Fibrinogen and Factor XIII Using Double-Filtration Plasmapheresis for Antibody-Mediated Rejection: Predictive Models.
Jouve T; Marlu R; Malvezzi P; Seyve L; Maurizi J; Carron PL; Polack B; Rostaing L
Blood Purif; 2018; 46(3):239-245. PubMed ID: 29972828
[TBL] [Abstract][Full Text] [Related]
5. A controlled study of double filtration plasmapheresis in the treatment of active rheumatoid arthritis.
Yu X; Ma J; Tian J; Jiang S; Xu P; Han H; Wang L
J Clin Rheumatol; 2007 Aug; 13(4):193-8. PubMed ID: 17762452
[TBL] [Abstract][Full Text] [Related]
6. Factor XIII V34L polymorphism modulates the risk of chronic venous leg ulcer progression and extension.
Gemmati D; Tognazzo S; Serino ML; Fogato L; Carandina S; De Palma M; Izzo M; De Mattei M; Ongaro A; Scapoli GL; Caruso A; Liboni A; Zamboni P
Wound Repair Regen; 2004; 12(5):512-7. PubMed ID: 15453833
[TBL] [Abstract][Full Text] [Related]
7. [Congenital factor XIII deficiency required high-dose factor XIII concentrate in late pregnancy].
Takahashi T; Hatao K; Suzukawa M; Oji T
Rinsho Ketsueki; 2007 May; 48(5):418-20. PubMed ID: 17571589
[TBL] [Abstract][Full Text] [Related]
8. Reduced levels of coagulation factor XIII in patients with advanced tumor disease.
Born P; Lippl F; Ulm K; Gerein P; Lersch C; Eckel F; Fischer G; Sandschin W; Dlaska U; Classen M
Hepatogastroenterology; 2000; 47(31):194-8. PubMed ID: 10690608
[TBL] [Abstract][Full Text] [Related]
9. [Double filtration plasmapheresis (DFPP) in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)].
Kumazawa K; Yuasa N; Mitsuma T; Nagamatsu M; Sobue G
Rinsho Shinkeigaku; 1998 Aug; 38(8):719-23. PubMed ID: 9916516
[TBL] [Abstract][Full Text] [Related]
10. Selective plasma exchange can reduce auto-antibodies in patients with bullous pemphigoid without affecting factor XIII and fibrinogen.
Nasu K; Hanafusa N; Nangaku M
J Clin Apher; 2017 Dec; 32(6):589-591. PubMed ID: 27709645
[TBL] [Abstract][Full Text] [Related]
11. Effect of post-transplant double filtration plasmapheresis on recurrent focal and segmental glomerulosclerosis in renal transplant recipients.
Otsubo S; Tanabe K; Shinmura H; Ishikawa N; Tokumoto T; Hattori M; Ito K; Nitta K; Akiba T; Nihei H; Toma H
Ther Apher Dial; 2004 Aug; 8(4):299-304. PubMed ID: 15274681
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment by double filtrate plasmapheresis in a pregnant woman with the rare P blood group and a history of multiple early miscarriages.
Hanafusa N; Noiri E; Yamashita T; Kondo Y; Suzuki M; Watanabe Y; Kanai T; Miyashita E; Tsuno NH; Fujii T; Kozuma S; Takahashi K; Taketani Y; Nakao A; Fujita T
Ther Apher Dial; 2006 Dec; 10(6):498-503. PubMed ID: 17199881
[TBL] [Abstract][Full Text] [Related]
13. Factor XIII deficiency.
Hsieh L; Nugent D
Haemophilia; 2008 Nov; 14(6):1190-200. PubMed ID: 19141159
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and tolerability of factor XIII concentrates prepared from human placenta or plasma: a crossover randomised study.
Brackmann HH; Egbring R; Ferster A; Fondu P; Girardel JM; Kreuz W; Masure R; Miloszewski K; Stibbe J; Zimmermann R
Thromb Haemost; 1995 Aug; 74(2):622-5. PubMed ID: 8584996
[TBL] [Abstract][Full Text] [Related]
15. Effect of double-filtration plasmapheresis for antibody-mediated rejection on hemostasis parameters and thrombin generation.
Marlu R; Malvezzi P; Seyve L; Jouve T; Maurizi J; Defendi F; Carron PL; Christophe M; Le Gouellec A; Polack B; Rostaing L
Thromb Res; 2018 Jun; 166():113-121. PubMed ID: 29747114
[TBL] [Abstract][Full Text] [Related]
16. Factor XIII Deficiency.
Karimi M; Bereczky Z; Cohan N; Muszbek L
Semin Thromb Hemost; 2009 Jun; 35(4):426-38. PubMed ID: 19598071
[TBL] [Abstract][Full Text] [Related]
17. Study of plasma levels of soluble CD40 ligand in systemic lupus erythematosus patients who have undergone plasmapheresis.
Kimura K; Tsuda H; Kwangseok Y; Tamura N; Kanai Y; Kobayashi S
Ther Apher Dial; 2005 Feb; 9(1):64-8. PubMed ID: 15828909
[TBL] [Abstract][Full Text] [Related]
18. Factor XIII: congenital deficiency factor XIII, acquired deficiency, factor XIII A-subunit, and factor XIII B-subunit.
Tahlan A; Ahluwalia J
Arch Pathol Lab Med; 2014 Feb; 138(2):278-81. PubMed ID: 24476525
[TBL] [Abstract][Full Text] [Related]
19. A case of acquired FXIII deficiency with severe bleeding symptoms.
Hayashi T; Kadohira Y; Morishita E; Asakura H; Souri M; Ichinose A
Haemophilia; 2012 Jul; 18(4):618-20. PubMed ID: 22356719
[TBL] [Abstract][Full Text] [Related]
20. Double-filtration plasmapheresis.
Tanabe K
Transplantation; 2007 Dec; 84(12 Suppl):S30-2. PubMed ID: 18162985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]